Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IgPro20 (Hizentra) in Primary Immunodeficiency
NCT00419341Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Nov 2006
- Primary completion
- Oct 2008
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of IgPro10 in Primary Humoral Immunodeficiency, sponsored by CSL Limited. Primary endpoints: Annualized Rate of Clinically Documented Serious Bacterial Infections at 12 months and Area Under the Concentration-time Curve of Total Serum Immunoglobulin G at 12 weeks. Started Nov 2006; status: completed.
02
Drugs
IgPro10
03
Conditions
Primary Humoral Immunodeficiency
Beyond the preview
Go deeper on NCT00419341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419341.